Title: The Impact of a Transjugular Intrahepatic Portosystemic Shunt on the Pharmacokinetics of Caspofungin in a Critically Ill Patient
Authors: Spriet, Isabel ×
Meyfroidt, Geert
Maleux, Geert
Verslype, Chris
Willems, Ludo #
Issue Date: 2012
Publisher: S. Karger
Series Title: Pharmacology vol:90 issue:5-6 pages:247-250
Abstract: Background: Caspofungin is the first echinocandin approved for the treatment of invasive fungal infections (IFI). As it is also well tolerated in patients with liver cirrhosis, caspofungin is an alternative for azoles in the treatment of IFI in patients with hepatic insufficiency. Methods: We report, for the first time, the pharmacokinetics (PK) of caspofungin in a patient with Child A cirrhosis and a transjugular intrahepatic portosystemic shunt (TIPS) and compare values to previously published results. Results: Caspofungin plasma levels were determined on days 14 (before TIPS reduction) and 29 (after TIPS reduction) of treatment. Troughs and peaks were 3.55 and 3.34 mg/l on day 14 and 9.28 and 9.49 mg/l on day 29, resulting in, (1) PK parameters only slightly higher than previously reported results in healthy volunteers and patients with Child A liver cirrhosis without TIPS and (2) similar exposures before versus after TIPS reduction. This limited increase in exposure is not expected to be correlated to toxicity. Conclusion: Caspofungin is a safe alternative for azoles when treating patients with TIPS suffering from IFI.
ISSN: 0031-7012
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Radiology
Laboratory of Intensive Care Medicine
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science